These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27881716)

  • 1. Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.
    Tang J; Li D; Drake L; Yuan W; Deschaine S; Morin EE; Ackermann R; Olsen K; Smith DE; Schwendeman A
    J Lipid Res; 2017 Jan; 58(1):124-136. PubMed ID: 27881716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.
    Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A
    Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623
    [No Abstract]   [Full Text] [Related]  

  • 3. Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.
    Fawaz MV; Kim SY; Li D; Ming R; Xia Z; Olsen K; Pogozheva ID; Tesmer JJG; Schwendeman A
    J Pharmacol Exp Ther; 2020 Feb; 372(2):193-204. PubMed ID: 31776208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo.
    Yuan W; Ernst K; Kuai R; Morin EE; Yu M; Sviridov DO; Tang J; Mei L; Li D; Ackermann R; Remaley AT; Schwendeman A
    Nanomedicine; 2023 Feb; 48():102646. PubMed ID: 36549559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.
    Li D; Fawaz MV; Morin EE; Ming R; Sviridov D; Tang J; Ackermann R; Olsen K; Remaley AT; Schwendeman A
    Mol Pharm; 2018 Jan; 15(1):83-96. PubMed ID: 29141139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
    Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
    Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
    Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation.
    Kim SY; Kang J; Fawaz MV; Yu M; Xia Z; Morin EE; Mei L; Olsen K; Li XA; Schwendeman A
    Nanomedicine (Lond); 2023 Dec; 18(29):2127-2142. PubMed ID: 38197376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
    Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
    EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MD simulations suggest important surface differences between reconstituted and circulating spherical HDL.
    Segrest JP; Jones MK; Catte A
    J Lipid Res; 2013 Oct; 54(10):2718-32. PubMed ID: 23856070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
    Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
    Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis.
    Jayaraman S; Cavigiolio G; Gursky O
    Biochem J; 2012 Mar; 442(3):703-12. PubMed ID: 22150513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits.
    Parolini C; Adorni MP; Busnelli M; Manzini S; Cipollari E; Favari E; Lorenzon P; Ganzetti GS; Fingerle J; Bernini F; Chiesa G
    Can J Cardiol; 2019 Oct; 35(10):1400-1408. PubMed ID: 31495683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
    de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
    J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
    Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties.
    Schwendeman A; Sviridov DO; Yuan W; Guo Y; Morin EE; Yuan Y; Stonik J; Freeman L; Ossoli A; Thacker S; Killion S; Pryor M; Chen YE; Turner S; Remaley AT
    J Lipid Res; 2015 Sep; 56(9):1727-37. PubMed ID: 26117661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.